Topoisomerase II
7 drugs Oncology
10
approved indications
7
Approved Drugs
6
Companies
13
Indications
1
Therapeutic Areas
Top Drugs
Unlock Full Target Intelligence PRO
✓ Competitive landscape by company (6 companies)
✓ All 7 approved drugs
✓ Therapeutic area breakdown
✓ Full indication list (13 indications)
✓ Patent cliff analysis
✓ Clinical trials pipeline
Upgrade to Pro
Starting at $99/mo
Drugs by Company
Pfizer 2 drugs
AYANA PHARMA LTD 1 drug
Baxter 1 drug
By Therapeutic Area
Oncology 6 drugs
Other 1 drugs
Drugs by Company PRO
Pfizer 2 drugs
AYANA PHARMA LTD 1 drug
Baxter 1 drug
AVYXA HOLDINGS 1 drug
JAZZ PHARMS THERAP 1 drug
EPIC PHARMA LLC 1 drug
By Therapeutic Area
Oncology 6 drugs
DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL), DOXIL (LIPOSOMAL), AVOPEF, ELLENCE +2 more
Other 1 drugs
EPIRUBICIN HYDROCHLORIDE
Indications Treated
Breast CancerAcute Lymphoblastic LeukemiaAcute Myeloblastic LeukemiaHodgkin LymphomaNon-Hodgkin LymphomaWilms' TumorNeuroblastomaSoft Tissue SarcomaBone SarcomaOvarian CarcinomaAcute Myeloid LeukemiaTesticular CancerSmall Cell Lung Cancer
All Drugs Targeting Topoisomerase II
| Drug | Company | Approved | Indications | Therapeutic Area |
|---|---|---|---|---|
| DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL) Top | AYANA PHARMA LTD | 2013 | 10 | Oncology |
| DOXIL (LIPOSOMAL) Top | Baxter | 1995 | 10 | Oncology |
| AVOPEF | AVYXA HOLDINGS | 2026 | 2 | Oncology |
| ELLENCE | Pfizer | 1999 | 1 | Oncology |
| VYXEOS | JAZZ PHARMS THERAP | 2017 | 1 | Oncology |
| IDAMYCIN PFS | Pfizer | 1997 | 1 | Oncology |
| EPIRUBICIN HYDROCHLORIDE | EPIC PHARMA LLC | 2006 | - |